Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction charts

European Journal of Epidemiology

Volumn 28, Issue 7, 2013, Pages 551-555

  Faeh, David ^a   Rohrmann, Sabine ^a   Braun, Julia ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Glycated hemoglobin; Mortality; Risk prediction; Risk scores

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY ANALYSIS; SMOKING; STATISTICAL MODEL; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MORTALITY; NUTRITION SURVEYS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; SMOKING; SURVIVAL RATE; UNITED STATES;

EID: 84884291772     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-013-9827-6     Document Type: Article

References (12)

1. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987-1003.
2. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular munster (PROCAM) study. Circulation. 2002;105(3):310-5.
3. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286(2):180-7.
4. Faeh D, Braun J, Bopp M. Body mass index vs cholesterol in cardiovascular disease risk prediction models. Arch Intern Med. 2012;172(22):1766-8.
5. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362(9):800-11.
6. National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat 1. 1994(32):1-407.
7. Royston P, Explained variation for survival models. Stata J (2006) 2006; 6(1):83-96.
8. Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128-38.
9. Gneiting T, Raftery AE. Strictly proper scoring rules, prediction and estimation. J Am Stat Assoc. 2007;102:359-78.
10. Nishimura R, Nakagami T, Sone H, Ohashi Y, Tajima N. Relationship between hemoglobin A1c and cardiovascular disease in mild-to-moderate hypercholesterolemic Japanese individuals: subanalysis of a large-scale randomized controlled trial. Cardiovasc Diabetol. 2011;10:58.
11. Orchard TJ, Temprosa M, Goldberg R, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the diabetes prevention program randomized trial. Ann Intern Med. 2005;142(8):611-9.
12. Iqbal N, Rubenstein AH. Does lowering of blood glucose improve cardiovascular morbidity and mortality? Clin J Am Soc Nephrol. 2008;3(1):163-7.